経口抗糖尿病（OAD）治療の世界市場：市場規模・現状・予測

• 英文タイトル：Global Oral Antidiabetic (OAD) Treatment Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9ST04229 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

※当調査レポートでは、経口抗糖尿病（OAD）治療の世界市場について調査・分析し、経口抗糖尿病（OAD）治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（スルホニル尿素、ビグアナイド、腸管α-グルコシダーゼ阻害剤、その他）、用途別（病院、診療所、糖尿病治療センター、その他）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の経口抗糖尿病（OAD）治療市場動向 ・主要企業別マーケットシェア ・経口抗糖尿病（OAD）治療の種類別市場規模2014-2019 （スルホニル尿素、ビグアナイド、腸管α-グルコシダーゼ阻害剤、その他） ・経口抗糖尿病（OAD）治療の用途別市場規模2014-2019 （病院、診療所、糖尿病治療センター、その他） ・経口抗糖尿病（OAD）治療の北米市場：主要企業・種類別/用途別市場規模 ・経口抗糖尿病（OAD）治療のヨーロッパ市場：主要企業・種類別/用途別市場規模 ・経口抗糖尿病（OAD）治療の中国市場：主要企業・種類別/用途別市場規模 ・経口抗糖尿病（OAD）治療の日本国内市場：主要企業・種類別/用途別市場規模 ・経口抗糖尿病（OAD）治療の東南アジア市場：主要企業・種類別/用途別市場規模 ・経口抗糖尿病（OAD）治療のインド市場：主要企業・種類別/用途別市場規模 ・経口抗糖尿病（OAD）治療の中南米市場：主要企業・種類別/用途別市場規模 ・主要企業のプロフィール （Pfizer、Eli Lilly、Merck、Sanofi、AstraZeneca、Glenmark、Novartis、Boehringer Ingelheim、Novo Nordisk、Mannkind） ・経口抗糖尿病（OAD）治療の市場規模予測2019-2025 （種類別、用途別、地域別市場予測） ・アナリストの観点・結論 ...

Diabetic is the condition where the sugar (glucose) level is high in the blood or the production of the insulin is inadequate. Diabetes main type the very first one is Type 1 and the second is Type 2, both the diabetic are most commonly find in the current scenario, apart from this many other diabetics case are also been listed as gestational diabetes and others. Various treatment method are present in the market injection, oral and others. The mostly used method of treatment or managing the diabetes is the oral.North America has the 44.3 million population with diabetes in 2015 according to the IDF, same as Europe have 59.8 million in 2015 according to IDF and Asia Pacific has 60% diabetic population as compared with world according to Asian Diabetes Prevention Initiative.
In 2018, the global Oral Antidiabetic (OAD) Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Oral Antidiabetic (OAD) Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Oral Antidiabetic (OAD) Treatment development in United States, Europe and China.

The key players covered in this study
Pfizer
Eli Lilly
Merck
Sanofi
AstraZeneca
Glenmark
Novartis
Boehringer Ingelheim
Novo Nordisk
Mannkind

Market segment by Type, the product can be split into
Sulphonylureas
Biguanides
Intestinal α-Glucosidase Inhibitors
Others

Market segment by Application, split into
Hospital
Clinics
Diabetics Treatment Centres
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Oral Antidiabetic (OAD) Treatment status, future forecast, growth opportunity, key market and key players.
To present the Oral Antidiabetic (OAD) Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Oral Antidiabetic (OAD) Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Sulphonylureas
1.4.3 Biguanides
1.4.4 Intestinal α-Glucosidase Inhibitors
1.4.5 Others
1.5 Market by Application
1.5.1 Global Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2025)
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Diabetics Treatment Centres
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Oral Antidiabetic (OAD) Treatment Market Size
2.2 Oral Antidiabetic (OAD) Treatment Growth Trends by Regions
2.2.1 Oral Antidiabetic (OAD) Treatment Market Size by Regions (2014-2025)
2.2.2 Oral Antidiabetic (OAD) Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Oral Antidiabetic (OAD) Treatment Market Size by Manufacturers
3.1.1 Global Oral Antidiabetic (OAD) Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Oral Antidiabetic (OAD) Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Oral Antidiabetic (OAD) Treatment Key Players Head office and Area Served
3.3 Key Players Oral Antidiabetic (OAD) Treatment Product/Solution/Service
3.4 Date of Enter into Oral Antidiabetic (OAD) Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019)
4.2 Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
5.2 Oral Antidiabetic (OAD) Treatment Key Players in United States
5.3 United States Oral Antidiabetic (OAD) Treatment Market Size by Type
5.4 United States Oral Antidiabetic (OAD) Treatment Market Size by Application

6 Europe
6.1 Europe Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
6.2 Oral Antidiabetic (OAD) Treatment Key Players in Europe
6.3 Europe Oral Antidiabetic (OAD) Treatment Market Size by Type
6.4 Europe Oral Antidiabetic (OAD) Treatment Market Size by Application

7 China
7.1 China Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
7.2 Oral Antidiabetic (OAD) Treatment Key Players in China
7.3 China Oral Antidiabetic (OAD) Treatment Market Size by Type
7.4 China Oral Antidiabetic (OAD) Treatment Market Size by Application

8 Japan
8.1 Japan Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
8.2 Oral Antidiabetic (OAD) Treatment Key Players in Japan
8.3 Japan Oral Antidiabetic (OAD) Treatment Market Size by Type
8.4 Japan Oral Antidiabetic (OAD) Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
9.2 Oral Antidiabetic (OAD) Treatment Key Players in Southeast Asia
9.3 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Type
9.4 Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Application

10 India
10.1 India Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
10.2 Oral Antidiabetic (OAD) Treatment Key Players in India
10.3 India Oral Antidiabetic (OAD) Treatment Market Size by Type
10.4 India Oral Antidiabetic (OAD) Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Oral Antidiabetic (OAD) Treatment Market Size (2014-2019)
11.2 Oral Antidiabetic (OAD) Treatment Key Players in Central & South America
11.3 Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Type
11.4 Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Application

12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Oral Antidiabetic (OAD) Treatment Introduction
12.1.4 Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 Eli Lilly
12.2.1 Eli Lilly Company Details
12.2.2 Company Description and Business Overview
12.2.3 Oral Antidiabetic (OAD) Treatment Introduction
12.2.4 Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.2.5 Eli Lilly Recent Development
12.3 Merck
12.3.1 Merck Company Details
12.3.2 Company Description and Business Overview
12.3.3 Oral Antidiabetic (OAD) Treatment Introduction
12.3.4 Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.3.5 Merck Recent Development
12.4 Sanofi
12.4.1 Sanofi Company Details
12.4.2 Company Description and Business Overview
12.4.3 Oral Antidiabetic (OAD) Treatment Introduction
12.4.4 Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.4.5 Sanofi Recent Development
12.5 AstraZeneca
12.5.1 AstraZeneca Company Details
12.5.2 Company Description and Business Overview
12.5.3 Oral Antidiabetic (OAD) Treatment Introduction
12.5.4 AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.5.5 AstraZeneca Recent Development
12.6 Glenmark
12.6.1 Glenmark Company Details
12.6.2 Company Description and Business Overview
12.6.3 Oral Antidiabetic (OAD) Treatment Introduction
12.6.4 Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.6.5 Glenmark Recent Development
12.7 Novartis
12.7.1 Novartis Company Details
12.7.2 Company Description and Business Overview
12.7.3 Oral Antidiabetic (OAD) Treatment Introduction
12.7.4 Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.7.5 Novartis Recent Development
12.8 Boehringer Ingelheim
12.8.1 Boehringer Ingelheim Company Details
12.8.2 Company Description and Business Overview
12.8.3 Oral Antidiabetic (OAD) Treatment Introduction
12.8.4 Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.8.5 Boehringer Ingelheim Recent Development
12.9 Novo Nordisk
12.9.1 Novo Nordisk Company Details
12.9.2 Company Description and Business Overview
12.9.3 Oral Antidiabetic (OAD) Treatment Introduction
12.9.4 Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.9.5 Novo Nordisk Recent Development
12.10 Mannkind
12.10.1 Mannkind Company Details
12.10.2 Company Description and Business Overview
12.10.3 Oral Antidiabetic (OAD) Treatment Introduction
12.10.4 Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
12.10.5 Mannkind Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Oral Antidiabetic (OAD) Treatment Key Market Segments
Table Key Players Oral Antidiabetic (OAD) Treatment Covered
Table Global Oral Antidiabetic (OAD) Treatment Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type 2014-2025
Figure Sulphonylureas Figures
Table Key Players of Sulphonylureas
Figure Biguanides Figures
Table Key Players of Biguanides
Figure Intestinal α-Glucosidase Inhibitors Figures
Table Key Players of Intestinal α-Glucosidase Inhibitors
Figure Others Figures
Table Key Players of Others
Table Global Oral Antidiabetic (OAD) Treatment Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Case Studies
Figure Clinics Case Studies
Figure Diabetics Treatment Centres Case Studies
Figure Others Case Studies
Figure Oral Antidiabetic (OAD) Treatment Report Years Considered
Table Global Oral Antidiabetic (OAD) Treatment Market Size 2014-2025 (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2014-2025 (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions 2014-2019 (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2014-2019
Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2014-2019
Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Regions 2019
Table Market Top Trends
Table Global Oral Antidiabetic (OAD) Treatment Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Share by Manufacturers (2014-2019)
Figure Global Oral Antidiabetic (OAD) Treatment Market Share by Manufacturers in 2018
Table Global Oral Antidiabetic (OAD) Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Oral Antidiabetic (OAD) Treatment Product/Solution/Service
Table Date of Enter into Oral Antidiabetic (OAD) Treatment Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size Share by Type (2014-2019)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Type (2014-2019)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Global Oral Antidiabetic (OAD) Treatment Market Size Share by Application (2014-2019)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Market Share by Application (2014-2019)
Figure Global Oral Antidiabetic (OAD) Treatment Revenue Market Share by Application in 2018
Figure United States Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table United States Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table United States Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table United States Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table United States Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table United States Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table United States Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Figure Europe Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table Europe Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table Europe Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table Europe Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Europe Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table Europe Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Europe Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Figure China Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table China Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table China Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table China Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-20189) (Million US$)
Table China Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table China Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table China Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Figure Japan Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table Japan Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table Japan Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table Japan Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Japan Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table Japan Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Japan Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Figure India Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table India Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table India Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table India Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table India Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table India Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table India Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Figure Central & South America Oral Antidiabetic (OAD) Treatment Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Oral Antidiabetic (OAD) Treatment Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Oral Antidiabetic (OAD) Treatment Market Share (2018-2019)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Type (2014-2019) (Million US$)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Share by Type (2014-2019)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Size by Application (2014-2019) (Million US$)
Table Central & South America Oral Antidiabetic (OAD) Treatment Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Pfizer Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Eli Lilly Recent Development
Table Merck Company Details
Table Merck Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Merck Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Sanofi Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table AstraZeneca Recent Development
Table Glenmark Company Details
Table Glenmark Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Glenmark Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Glenmark Recent Development
Table Novartis Company Details
Table Novartis Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Novartis Recent Development
Table Boehringer Ingelheim Company Details
Table Boehringer Ingelheim Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Boehringer Ingelheim Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Boehringer Ingelheim Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Novo Nordisk Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Novo Nordisk Recent Development
Table Mannkind Company Details
Table Mannkind Revenue in Oral Antidiabetic (OAD) Treatment Business (2014-2019)(Million US$)
Figure Mannkind Revenue Growth Rate in Oral Antidiabetic (OAD) Treatment Business (2014-2019)
Table Mannkind Recent Development
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Regions (Million US$) 2019-2025
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Share by Regions (2019-2025)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size Share by Regions in 2025
Figure United States Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Europe Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure China Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Japan Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure India Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Oral Antidiabetic (OAD) Treatment Market Size Forecast (2019-2025)(Million USD)
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Product (2019-2025) (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Product (2019-2025)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Product in 2025
Table Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2025) (Million US$)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Application (2019-2025)
Figure Global Oral Antidiabetic (OAD) Treatment Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---